chr6-3225525-C-A

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_178012.5(TUBB2B):​c.564G>T​(p.Ser188Ser) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0203 in 1,570,210 control chromosomes in the GnomAD database, including 1,536 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Synonymous variant affecting the same amino acid position (i.e. S188S) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.052 ( 244 hom., cov: 31)
Exomes 𝑓: 0.017 ( 1292 hom. )

Consequence

TUBB2B
NM_178012.5 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: -5.28

Publications

7 publications found
Variant links:
Genes affected
TUBB2B (HGNC:30829): (tubulin beta 2B class IIb) The protein encoded by this gene is a beta isoform of tubulin, which binds GTP and is a major component of microtubules. This gene is highly similar to TUBB2A and TUBB2C. Defects in this gene are a cause of asymmetric polymicrogyria. [provided by RefSeq, Mar 2010]
TUBB2B Gene-Disease associations (from GenCC):
  • complex cortical dysplasia with other brain malformations
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • complex cortical dysplasia with other brain malformations 7
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), G2P, Orphanet
  • congenital fibrosis of extraocular muscles
    Inheritance: AD Classification: SUPPORTIVE, LIMITED Submitted by: Orphanet, Genomics England PanelApp
  • tubulinopathy-associated dysgyria
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • cerebellar ataxia, intellectual disability, and dysequilibrium
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.77).
BP6
Variant 6-3225525-C-A is Benign according to our data. Variant chr6-3225525-C-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 137854.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-5.28 with no splicing effect.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.222 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TUBB2BNM_178012.5 linkc.564G>T p.Ser188Ser synonymous_variant Exon 4 of 4 ENST00000259818.8 NP_821080.1 Q9BVA1A0A384MEE3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TUBB2BENST00000259818.8 linkc.564G>T p.Ser188Ser synonymous_variant Exon 4 of 4 1 NM_178012.5 ENSP00000259818.6 Q9BVA1

Frequencies

GnomAD3 genomes
AF:
0.0523
AC:
7173
AN:
137108
Hom.:
243
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.131
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.119
Gnomad ASJ
AF:
0.00434
Gnomad EAS
AF:
0.232
Gnomad SAS
AF:
0.0606
Gnomad FIN
AF:
0.00841
Gnomad MID
AF:
0.0127
Gnomad NFE
AF:
0.00187
Gnomad OTH
AF:
0.0416
GnomAD2 exomes
AF:
0.0404
AC:
9283
AN:
230044
AF XY:
0.0346
show subpopulations
Gnomad AFR exome
AF:
0.0911
Gnomad AMR exome
AF:
0.139
Gnomad ASJ exome
AF:
0.00221
Gnomad EAS exome
AF:
0.205
Gnomad FIN exome
AF:
0.00507
Gnomad NFE exome
AF:
0.000813
Gnomad OTH exome
AF:
0.0218
GnomAD4 exome
AF:
0.0172
AC:
24641
AN:
1433012
Hom.:
1292
Cov.:
34
AF XY:
0.0172
AC XY:
12263
AN XY:
712252
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.0988
AC:
2261
AN:
22890
American (AMR)
AF:
0.173
AC:
7390
AN:
42806
Ashkenazi Jewish (ASJ)
AF:
0.00299
AC:
78
AN:
26070
East Asian (EAS)
AF:
0.214
AC:
7844
AN:
36632
South Asian (SAS)
AF:
0.0519
AC:
4113
AN:
79268
European-Finnish (FIN)
AF:
0.00763
AC:
394
AN:
51614
Middle Eastern (MID)
AF:
0.0154
AC:
85
AN:
5530
European-Non Finnish (NFE)
AF:
0.000982
AC:
1090
AN:
1109902
Other (OTH)
AF:
0.0238
AC:
1386
AN:
58300
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.391
Heterozygous variant carriers
0
1036
2071
3107
4142
5178
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
374
748
1122
1496
1870
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0524
AC:
7190
AN:
137198
Hom.:
244
Cov.:
31
AF XY:
0.0569
AC XY:
3813
AN XY:
66976
show subpopulations
African (AFR)
AF:
0.131
AC:
3773
AN:
28844
American (AMR)
AF:
0.120
AC:
1745
AN:
14600
Ashkenazi Jewish (ASJ)
AF:
0.00434
AC:
15
AN:
3456
East Asian (EAS)
AF:
0.233
AC:
1091
AN:
4680
South Asian (SAS)
AF:
0.0598
AC:
269
AN:
4498
European-Finnish (FIN)
AF:
0.00841
AC:
86
AN:
10220
Middle Eastern (MID)
AF:
0.0103
AC:
3
AN:
292
European-Non Finnish (NFE)
AF:
0.00187
AC:
127
AN:
67756
Other (OTH)
AF:
0.0418
AC:
81
AN:
1940
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.410
Heterozygous variant carriers
0
240
480
719
959
1199
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
80
160
240
320
400
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00706
Hom.:
5

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:3
Mar 19, 2014
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Feb 08, 2013
Genetic Services Laboratory, University of Chicago
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jun 07, 2017
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:2
Jan 30, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.77
CADD
Benign
0.20
DANN
Benign
0.65
PhyloP100
-5.3
Mutation Taster
=98/2
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.050
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2259136; hg19: chr6-3225759; COSMIC: COSV52534604; API